Spotlight Investment: Gemphire Therapeutics
May 8, 2015
Novel drugs developer to treat unmet medical needs of patients with high cardiovascular and pancreatitis risks with goals beyond those of current therapies.
Novel drugs developer to treat unmet medical needs of patients with high cardiovascular and pancreatitis risks with goals beyond those of current therapies.
Histotripsy is a non-invasive soft tissue ablation modality that mechanically homogenizes target tissue resulting in complete cellular destruction with no thermal injury.